SCHEMBL3633703

SCHEMBL3633703

CCCn1c(-c2ccc(Cl)nn2)nc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 5/20 0.53
LMNA P02545 3/20 0.53
HPGD P15428 3/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 2/20 0.53
GAA P10253 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
POLB P06746 1/20 0.51
MAPT P10636 3/20 0.51
HTT P42858 2/20 0.50
CYP11B1 P15538 1/20 0.48
TP53 P04637 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 1/20 0.47
ALOX15 P16050 1/20 0.47
KMT2A Q03164 1/20 0.47
GRM5 P41594 2/20 0.46
BRD4 O60885 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3628373 0.84 ALDH1A1 (0.56) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL3629788 0.82 GRM5 (0.47) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL13872509 0.81 MEN1 (0.58) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL3633636 0.80 MAPT (0.63) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL3631813 0.77 MEN1 (0.69) KDM4EALDH1A1LMNAHPGDTSHR
Hydrochloric Acid SCHEMBL7175710 0.77 MAPT (0.59) KDM4EALDH1A1LMNAHPGDTSHR
Hydrochloric Acid SCHEMBL7180527 0.77 MAPT (0.59) KDM4EALDH1A1LMNAHPGDTSHR
Hydrochloric Acid SCHEMBL7175705 0.77 MAPT (0.59) KDM4EALDH1A1LMNAHPGDTSHR
Hydrochloric Acid SCHEMBL7178837 0.77 MAPT (0.59) KDM4EALDH1A1LMNAHPGDTSHR
Hydrochloric Acid SCHEMBL7172156 0.77 MAPT (0.59) KDM4EALDH1A1LMNAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146969-A1 NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Novartis Ag (CH) 2010-01-27 EP disclosed
US-20090105266-A1 Organic compounds NOVARTIS AG (CH) 2009-04-23 US disclosed
WO-2008128968-A1 NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 NOVARTIS AG (CH) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105266-A1 Organic compounds SLCO2B1, SLCO1B1, SLCO1B3 KDM4E 2938/4885ALDH1A1 45/4885LMNA 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.